Patents by Inventor Marc Freeman

Marc Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic applications targeting SARM1
    Patent number: 9486521
    Abstract: The present disclosure provides methods for reducing axonal and/or synaptic degradation in neurons by modulating sterile ?/Armadillo/Toll-Interleukin receptor homology domain protein (SARM) activity and/or expression.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: November 8, 2016
    Assignees: University of Massachusetts, University of Miami
    Inventors: Marc Freeman, Stephan Zuchner
  • Therapeutic Applications Targeting SARM1
    Publication number: 20140079712
    Abstract: The present disclosure provides methods for reducing axonal and/or synaptic degradation in neurons by modulating sterile ?/Armadillo/Toll-Interleukin receptor homology domain protein (SARM) activity and/or expression.
    Type: Application
    Filed: November 22, 2013
    Publication date: March 20, 2014
    Applicants: UNIVERSITY OF MIAMI, UNIVERSITY OF MASSACHUSETTS
    Inventors: Marc Freeman, Stephan Zuchner
  • Therapeutic Applications Targeting SARM1
    Publication number: 20120328629
    Abstract: The present disclosure provides methods for reducing axonal and/or synaptic degradation in neurons by modulating sterile ?/Armadillo/Toll-Interleukin receptor homology domain protein (SARM) activity and/or expression.
    Type: Application
    Filed: June 22, 2012
    Publication date: December 27, 2012
    Applicants: UNIVERSITY OF MIAMI, UNIVERSITY OF MASSACHUSETTS
    Inventors: Marc Freeman, Stephan Zuchner